News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
741,431 Results
Type
Article (43765)
Company Profile (318)
Press Release (697335)
Multimedia
Podcasts (115)
Webinars (19)
Section
Business (210977)
Career Advice (2106)
Deals (36756)
Drug Delivery (123)
Drug Development (83409)
Employer Resources (176)
FDA (16817)
Job Trends (15497)
News (357323)
Policy (34123)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2610)
Accelerated approval (31)
Adcomms (26)
Allergies (145)
Alliances (51584)
ALS (173)
Alzheimer's disease (1684)
Antibody-drug conjugate (ADC) (319)
Approvals (17076)
Artificial intelligence (529)
Autoimmune disease (152)
Automation (37)
Bankruptcy (372)
Best Places to Work (11770)
BIOSECURE Act (21)
Biosimilars (193)
Biotechnology (188)
Bladder cancer (157)
Brain cancer (59)
Breast cancer (643)
Cancer (4841)
Cardiovascular disease (411)
Career advice (1785)
Career pathing (36)
CAR-T (283)
CDC (47)
Celiac Disease (2)
Cell therapy (748)
Cervical cancer (36)
Clinical research (71107)
Collaboration (1741)
Company closure (4)
Compensation (1157)
Complete response letters (61)
COVID-19 (2784)
CRISPR (93)
C-suite (852)
Cystic fibrosis (148)
Data (6219)
Decentralized trials (2)
Denatured (36)
Depression (134)
Diabetes (504)
Diagnostics (6764)
Digital health (45)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (256)
Drug pricing (202)
Drug shortages (31)
Duchenne muscular dystrophy (230)
Earnings (91797)
Editorial (58)
Employer branding (21)
Employer resources (155)
Events (120162)
Executive appointments (991)
FDA (19943)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1471)
Gene editing (199)
Generative AI (45)
Gene therapy (609)
GLP-1 (1012)
Government (4797)
Grass and pollen (7)
Guidances (384)
Healthcare (19053)
HIV (56)
Huntington's disease (45)
IgA nephropathy (83)
Immunology and inflammation (259)
Immuno-oncology (57)
Indications (105)
Infectious disease (3045)
Inflammatory bowel disease (193)
Inflation Reduction Act (14)
Influenza (111)
Intellectual property (247)
Interviews (326)
IPO (16919)
IRA (56)
Job creations (4068)
Job search strategy (1497)
JPM (63)
Kidney cancer (15)
Labor market (83)
Layoffs (574)
Leadership (32)
Legal (8422)
Liver cancer (92)
Longevity (15)
Lung cancer (652)
Lymphoma (377)
Machine learning (43)
Management (60)
Manufacturing (811)
MASH (166)
Medical device (13844)
Medtech (13896)
Mergers & acquisitions (20903)
Metabolic disorders (1295)
Multiple sclerosis (160)
NASH (17)
Neurodegenerative disease (318)
Neuropsychiatric disorders (89)
Neuroscience (2929)
Neurotech (1)
NextGen: Class of 2026 (6646)
Non-profit (4557)
Now hiring (65)
Obesity (613)
Opinion (283)
Ovarian cancer (166)
Pain (215)
Pancreatic cancer (224)
Parkinson's disease (281)
Partnered (34)
Patents (496)
Patient recruitment (482)
Peanut (58)
People (60864)
Pharmaceutical (90)
Pharmacy benefit managers (31)
Phase 1 (22072)
Phase 2 (31269)
Phase 3 (23427)
Pipeline (5206)
Policy (295)
Postmarket research (2655)
Preclinical (9380)
Press Release (68)
Prostate cancer (237)
Psychedelics (49)
Radiopharmaceuticals (284)
Rare diseases (857)
Real estate (6305)
Recruiting (72)
Regulatory (25340)
Reports (52)
Research institute (2435)
Resumes & cover letters (360)
Rett syndrome (27)
RNA editing (17)
RSV (76)
Schizophrenia (154)
Series A (243)
Series B (193)
Service/supplier (11)
Sickle cell disease (98)
Special edition (24)
Spinal muscular atrophy (160)
Sponsored (42)
Startups (3764)
State (2)
Stomach cancer (18)
Supply chain (106)
Tariffs (96)
The Weekly (77)
Vaccines (1019)
Venture capital (88)
Weight loss (402)
Women's health (89)
Worklife (18)
Date
Today (140)
Last 7 days (638)
Last 30 days (2210)
Last 365 days (30344)
2026 (3093)
2025 (30679)
2024 (35767)
2023 (40629)
2022 (51798)
2021 (56329)
2020 (54792)
2019 (47399)
2018 (35770)
2017 (33136)
2016 (32662)
2015 (38615)
2014 (32516)
2013 (27630)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (800)
Alabama (83)
Alaska (7)
Arizona (313)
Arkansas (14)
Asia (42132)
Australia (6743)
California (11264)
Canada (3286)
China (1130)
Colorado (477)
Connecticut (473)
Delaware (337)
Europe (90287)
Florida (1675)
Georgia (353)
Hawaii (3)
Idaho (61)
Illinois (871)
India (67)
Indiana (526)
Iowa (22)
Japan (434)
Kansas (125)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1382)
Massachusetts (8125)
Michigan (323)
Minnesota (626)
Mississippi (5)
Missouri (127)
Montana (31)
Nebraska (28)
Nevada (122)
New Hampshire (78)
New Jersey (2997)
New Mexico (29)
New York (2974)
North Carolina (1467)
North Dakota (8)
Northern California (5483)
Ohio (333)
Oklahoma (22)
Oregon (46)
Pennsylvania (2281)
Puerto Rico (23)
Rhode Island (47)
South America (1174)
South Carolina (66)
South Dakota (1)
Southern California (4386)
Tennessee (173)
Texas (1744)
United States (40063)
Utah (337)
Vermont (1)
Virginia (274)
Washington D.C. (81)
Washington State (925)
West Virginia (4)
Wisconsin (112)
Wyoming (2)
741,431 Results for "xeris pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
January 5, 2026
·
1 min read
Press Releases
Xeris Expects to Deliver Record Fourth Quarter and Full-Year 2025 Total Revenue
January 8, 2026
·
6 min read
Press Releases
Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 3, 2025
October 5, 2025
·
1 min read
Press Releases
Xeris Announces Notice of Allowance from U.S. Patent and Trademark Office for XP-8121 Patent Application
December 2, 2025
·
5 min read
Press Releases
Xeris Biopharma Posts Record Financial Results for the Third Quarter 2025
November 7, 2025
·
15 min read
Press Releases
Xeris Biopharma to Report Third Quarter 2025 Financial Results on November 6, 2025
October 24, 2025
·
1 min read
Press Releases
Xeris Announces Orange Book Listing of U.S. Patent for Recorlev®
August 25, 2025
·
7 min read
Press Releases
Xeris Biopharma to Report Second Quarter 2025 Financial Results on August 7, 2025
August 1, 2025
·
2 min read
Press Releases
Xeris Announces Details for Analyst & Investor Day
May 20, 2025
·
8 min read
BioMidwest
Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement with Beta Bionics
Xeris Biopharma Holdings, Inc. announced that it has entered into an exclusive worldwide collaboration and license agreement with Beta Bionics, Inc. for the development and commercialization of a glucagon product utilizing Xeris’ XeriSol™ technology for use in Beta Bionics’ proprietary bi-hormonal pump and pump systems.
May 6, 2024
·
6 min read
1 of 74,144
Next
